Stock Scorecard
Stock Summary for Quest Diagnostics Inc (DGX) - $197.82 as of 4/10/2026 7:11:41 PM EST
Total Score
11 out of 30
Safety Score
53 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DGX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DGX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DGX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DGX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DGX (53 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Financial Details for DGX
Company Overview |
|
|---|---|
| Ticker | DGX |
| Company Name | Quest Diagnostics Inc |
| Country | N/A |
| Description | Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 4/21/2026 |
Stock Price History |
|
| Last Day Price | 197.82 |
| Price 4 Years Ago | 145.99 |
| Last Day Price Updated | 4/10/2026 7:11:41 PM EST |
| Last Day Volume | 1,044,076 |
| Average Daily Volume | 817,837 |
| 52-Week High | 212.58 |
| 52-Week Low | 157.00 |
| Last Price to 52 Week Low | 26.00% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 32.57 |
| Sector PE | 38.13 |
| 5-Year Average PE | 12.74 |
| Free Cash Flow Ratio | 52.20 |
| Industry Free Cash Flow Ratio | 15.40 |
| Sector Free Cash Flow Ratio | 22.07 |
| Current Ratio Most Recent Quarter | 1.04 |
| Total Cash Per Share | 3.79 |
| Book Value Per Share Most Recent Quarter | 65.18 |
| Price to Book Ratio | 3.05 |
| Industry Price to Book Ratio | 7.26 |
| Sector Price to Book Ratio | 23.58 |
| Price to Sales Ratio Twelve Trailing Months | 1.97 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.22 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.73 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 110,685,000 |
| Market Capitalization | 21,895,706,700 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/6/2026 |
| Previous Dividend Amount | 0.8000 |
| Current Dividend Amount | 0.8600 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 3.26 |
| Trailing Annual Dividend Yield | 1.65% |
| Forward Annual Dividend Rate | 3.44 |
| Forward Annual Dividend Yield | 1.74% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 1.83% |
| 5-Year Average Dividend Yield | 1.94% |
| 1-Year Dividend Growth Rate Percentage | 9.21% |
| 3-Year Dividend Growth Rate Percentage | 4.50% |
| 5-Year Dividend Growth Rate Percentage | 7.25% |
| All-Time Dividend Growth Rate Percentage | 10.67% |
| Dividend Payout Ratio | 37.26% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 11.00% |
| Annual Earnings Growth | 13.89% |
| Reported EPS 12 Trailing Months | 8.75 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 9.85 |
| Net Income Twelve Trailing Months | 992,000,000 |
| Net Income Past Year | 992,000,000 |
| Net Income Prior Year | 871,000,000 |
| Quarterly Revenue Growth YOY | 7.10% |
| 5-Year Revenue Growth | 3.18% |
| Operating Margin Twelve Trailing Months | 14.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 420,000,000 |
| Total Cash Past Year | 420,000,000 |
| Total Cash Prior Year | 549,000,000 |
| Net Cash Position Most Recent Quarter | -4,747,000,000 |
| Net Cash Position Past Year | -4,747,000,000 |
| Long Term Debt Past Year | 5,167,000,000 |
| Long Term Debt Prior Year | 5,615,000,000 |
| Total Debt Most Recent Quarter | 5,167,000,000 |
| Equity to Debt Ratio Past Year | 0.58 |
| Equity to Debt Ratio Most Recent Quarter | 0.58 |
| Total Stockholder Equity Past Year | 7,170,000,000 |
| Total Stockholder Equity Prior Year | 6,778,000,000 |
| Total Stockholder Equity Most Recent Quarter | 7,170,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,359,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 12.28 |
| Free Cash Flow Past Year | 1,359,000,000 |
| Free Cash Flow Prior Year | 909,000,000 |
Options |
|
| Put/Call Ratio | 51.38 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.49 |
| MACD Signal | -0.65 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.65 |
| RSI | 51.11 |
| 50-Day SMA | 181.01 |
| 150-Day SMA | 152.26 |
| 200-Day SMA | 146.65 |
System |
|
| Modified | 4/10/2026 9:52:02 PM EST |